Market Chatter: Pfizer, Amgen Eyeing Hong Kong Expansion

MT Newswires Live04-20

Pfizer (PFE) and Amgen (AMGN) are among 22 strategic firms looking to expand in Hong Kong under the sixth batch of the government's flagship investment-attraction program, the South China Morning Post reported Monday, citing an unnamed source.

The two companies are expected to sign deals with the Office for Attracting Strategic Enterprises, the paper said.

Pfizer and Amgen did not immediately respond to MT Newswires' requests for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment